A new study on the effects of Ecologic Barrier published

We are glad to share a recent publication on Ecologic Barrier with you. This is a study conducted in Vietnam using the Ecologic Barrier product commercially named Cerebio. The study was designed to investigate the effects of CereBio in alleviating anxiety and depressive symptoms in patients with increased scores on the Hospital Anxiety and Depression Scale (HADS) as well as suffering from chronic GI-symptoms.

The publication describes the results of a non – controled trial study on patients with chronic GI complaints, and symptoms suggesting anxiety/depression but were not clinically diagnosed with either condition Eighty-three patients with a score of 8 or higher on anxiety or depression (according to the HADS) participated in this study. The patients used CereBio for two months. During the intervention period, the symptoms of anxiety and depression improved significantly, already after 4 weeks, and further after 8 weeks of use. The data shows that significant effects were found on the anxiety scores alone, the depressive scores alone and the combination. In addition to the reduced symptoms on anxiety and depression, the quality of life in this target group improved significantly, as measured by the EQ5D5L questionnaire. These findings are in line with our earlier findings with Ecologic Barrier^1,2, and are confirming that this product can be helpful in people with enhanced feelings of anxiety or depression.

Click here to read the publication.

1            Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity 2015; 48: 258–64.

2            Chahwan B, Kwan S, Isik A, van Hemert S, Burke C, Roberts L. Gut feelings: A randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. Journal of Affective Disorders 2019; 253: 317–26.